0.79 USD
▲+0.06+8.38%
盘后 0.80 0.00%
2026-11-20
市值
$260.55M
市盈率
—
EPS
-0.20
股息率
—
52 周区间
0.69 – 2.73
成交量
2.92M
Beta
1.98
目标价
12.17
52W 低 0.6952W 高 2.73
价格走势
公司简介
Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health. The company’s pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under ...